Need professional-grade analysis? Visit stockanalysis.com
$22.97B
30.29
3,126
1.65%
Yili Chuanning Biotechnology Co. Ltd. A (301301) trades on SHE in CNY. The company is classified in the Healthcare sector under the Biotechnology industry. The stock currently trades at CNY10.08, down 2.33% from the previous close.
Over the past year, 301301 has traded between a low of CNY9.82 and a high of CNY13.73. The stock has lost 16.2% over this period. It is currently 26.6% below its 52-week high.
Yili Chuanning Biotechnology Co. Ltd. A has a market capitalization of $22.97B, with a price-to-earnings ratio of 30.29 and a dividend yield of 1.65%.
Yili Chuanning Biotechnology Co.,Ltd., together with its subsidiaries, engages in the research, development, and industrialization of bio-fermentation technology and synthetic biology products in China and internationally. It offers antibiotic intermediates comprising erythromycin thiofluorate; cephalosporin intermediates consisting of 7-aminocephalosporanic acid (7-ACA), 7-amino-3-deacetoxycephalosporinic acid (7-ADCA), and D-7ACA; penicillin intermediates, such as 6-aminopenicillanic acid (6-APA) and penicillin G potassium salt; ursodeoxycholic acid; coenzyme Q10 mycelia; and other products. It also provides synthetic biology products, including bisabolol, 5-hydroxytryptophan, ergothioneine, ectoine, inositol, squalane, polyhydroxyalkanoate (PHA), and phytosphingosine. In addition, the company engages in trading, crop cultivation, detection, technical consultation, and asset investment activities. The company was incorporated in 2010 and is based in Yining, China. Yili Chuanning Biotechnology Co.,Ltd. operates as a subsidiary of Sichuan Kelun Pharmaceutical Co., Ltd.
Side-by-side comparison against top Healthcare peers.